Supply Chain

Although patients know hospital trips are expensive, they still often experience sticker shock when they view their medical bills — especially when these bills are itemized.

Last October, Democratic Gov. Jerry Brown signed a drug pricing transparency law, making California the first U.S. state to pass such legislation. While the law went into effect in January, it remains unclear whether it will successfully lower drug prices,…

Vas Narasimhan, MD, who assumed the CEO role at Novartis in February, has an infatuation with technology and thinks his drug company is ready to embrace it, according to Forbes.

Prices for many of the 20 most commonly prescribed brand-name drugs to Medicare Part D beneficiaries rose nearly 10 times more than the cost of inflation over a five-year period, according to a report released March 26 by Sen. Claire…

GlaxoSmithKline will purchase Novartis' 36.5 percent stake in their consumer healthcare joint venture for $13 billion, according to Reuters.

Operating room (OR) surgeons and nurses face extraordinary challenges, to say the least. The OR is among the most expensive hospital areas to run1, as well as one of the most stressful.

The FDA's Center for Devices and Radiological Health plans to expand its digital health pre-certification pilot program by the end of 2018, the center's associate director for digital health Bakul Patel said March 22, according to Regulatory Focus.

HHS Secretary Alex Azar selected CVS Caremark Vice President Daniel Best to lead the agency's push to curb drug prices, a source familiar with the hire told Politico.

The American Red Cross was forced to cancel more than 350 blood drives in March as a string of winter storms pummeled the U.S. — greatly depleting blood supply across the nation. 

Monteris Medical recalled its NeuroBlate System and coinciding Laser Delivery Probes due to numerous instances of device malfunctions, according to a March 22 recall alert from the FDA.